Table 4. Need for psychosocial care (HQ-S) and use of the professional support system (medical, psychosocial), n = 644–659.
| Using Support | HQ-S above cut off | χ ,, p | Odds Ratio | Confidence Limits | |||||
|---|---|---|---|---|---|---|---|---|---|
| Yes 236 (36%) | No 423 (64%) | ||||||||
| Dermatological aftercare | yes | 175 | 335 | 510 | 78% | ||||
| no | 59 | 84 | 143 | 22% | 0.74 | 0.51 | 1.09 | ||
| sum | 234 | 419 | 653 | 2.34, ≤ .05 | |||||
| Psychological counseling | yes | 39 | 8 | 47 | 7% | ||||
| no | 196 | 414 | 610 | 93% | 10.30 | 4.72 | 22.45 | ||
| sum | 235 | 422 | 657* | 49.11, ≤ .001 | |||||
| Psychotherapy (weekly) | yes | 20 | 5 | 25 | 4% | ||||
| no | 217 | 417 | 634 | 96% | 7.69 | 2.85 | 20.76 | ||
| sum | 237 | 422 | 659* | 21.88, ≤ .001 | |||||
| Any psychosocial care**: | yes | 59 | 26 | 85 | 13% | ||||
| no | 170 | 389 | 559 | 87% | 5.19 | 3.16 | 8.52 | ||
| sum | 229 | 415 | 644* | 48.97, ≤ .001 | |||||
| Psychopharmacologic drugs | yes | 34 | 12 | 46 | 7% | ||||
| no | 202 | 411 | 613 | 93% | 5.76 | 2.92 | 11.37 | ||
| sum | 236 | 423 | 659* | 31.23, ≤ .001 | |||||
2 x 2 contingency tables, Chi-square tests, odds ratios
*gap to n = 689 due to missing data,
**use of one or more of the following types: psychological counseling, social counseling, pastoral care, self-help group, cancer care counseling, telephone counseling, internet counseling, internet forum (concerned persons)